Background The cornerstone of standard treatment for patients with primary bone metastatic
prostate cancer (mPCa) is androgen deprivation therapy (ADT). Retrospective studies …

Context It remains unclear whether men with hormone-sensitive prostate cancer (PCa)
metastasized to nonregional lymph nodes (M1a) benefit from prostate-directed therapy …

Prostate cancer (PCa) is the main cause of cancer-related mortality in males and the
diagnosis, treatment, and care of these patients places a great burden on healthcare …

Background Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of
Drug Efficacy (STAMPEDE) trial showed the survival benefit for prostate radiotherapy in …

Purpose: We investigated the effect of race and age on the distribution of prostate cancer
metastases. Materials and Methods: Records for patients with metastatic prostate cancer …

Patients diagnosed with clinically node-positive prostate cancer represent a population that
has historically been thought to harbor systemic disease. Increasing evidence supports the …

Objectives To evaluate the association between the use of local radiotherapy (RT) with the
survival of patients with de novo metastatic prostate cancer and symptomatic local events …

Background A substantial number of patients will develop further biochemical progression
after radical prostatectomy (RP) and salvage radiotherapy (sRT). Recently published data …

Objective To test whether radical prostatectomy might result in better survival than external
beam radiation therapy in metastatic prostate cancer patients. Methods Newly diagnosed …

Introduction: We aimed to investigate the significance of lymph node metastasis from
hepatocellular carcinoma and the efficacy of local treatment. Methods: We included patients …